Lv1
18 积分 2025-04-10 加入
SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial
2天前
已完结
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
2天前
已完结
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime
16天前
已完结
New BTK Inhibitors May Combat Resistance in CLL
16天前
已完结
Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value
17天前
已完结
Cytogenetics and molecular genetics of myelodysplastic neoplasms
27天前
已完结
A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer
29天前
已完结
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
1个月前
已完结
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
1个月前
已完结
DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma
1个月前
已完结
皖公网安备34019202002308
